NAD+ IV Therapy | Epical HealthMed
Medically reviewed by Dr. Carlos A. Ramirez, MD, MBA, FAAFP, BCEM, IFM-C, FMCP-M (Epical HealthMed)
Last updated: January 26, 2026
NAD+ IV Therapy is a premium cellular-energy treatment designed for patients who need deeper mitochondrial support than a standard energy drip can provide. NAD+ is central to ATP production, stress recovery, and metabolic resilience, which is why this therapy is often positioned for burnout, brain fog, age-related decline in cellular energy, and longer-term restoration programs rather than quick hydration or same-day pick-me-up care.
Why NAD+ therapy is positioned as a premium service
NAD+ is not usually presented as a casual add-on because the treatment takes time, the infusion rate matters, and patient tolerance can shape the session. That makes it operationally different from faster wellness drips even when the patient is seeking a similar outcome such as better energy or mental clarity.
A strong page should explain this clearly so the patient understands that longer chair time and screening are part of the treatment model, not signs that something is wrong.
Who is usually a strong fit for NAD+ therapy
- Burnout and high-stress recovery
- Brain fog and cognitive fatigue
- Healthy aging and mitochondrial support
- Structured recovery programs that require more than simple hydration
Who is usually a strong fit for NAD+ therapy
This page usually serves patients dealing with deeper fatigue patterns, brain fog, performance decline, chronic stress, or longer-term recovery needs. It is also useful for patients who have outgrown standard energy drips and need a more intensive cellular-energy conversation.
Why approval and pacing protect the experience
NAD+ therapy often feels more premium when the page explains the logic behind its guardrails. Slow pacing improves tolerability, and approval steps help make sure the patient is investing time in the right therapy.
Educational content only. This page does not replace individualized medical advice. Always consult your clinician for diagnosis and treatment decisions.
Who is usually a strong fit for NAD+ therapy
This page usually serves patients dealing with deeper fatigue patterns, brain fog, performance decline, chronic stress, or longer-term recovery needs. It is also useful for patients who have outgrown standard energy drips and need a more intensive cellular-energy conversation.
- Burnout and high-stress recovery
- Brain fog and cognitive fatigue
- Healthy aging and mitochondrial support
- Structured recovery programs that require more than simple hydration
Why approval and pacing protect the experience
NAD+ therapy often feels more premium when the page explains the logic behind its guardrails. Slow pacing improves tolerability, and approval steps help make sure the patient is investing time in the right therapy.
Educational content only. This page does not replace individualized medical advice. Always consult your clinician for diagnosis and treatment decisions.
What to expect
Local care + telehealth: Epical HealthMed supports patients in Mission, Texas and surrounding communities, with telehealth options when clinically appropriate.
Frequently Asked Questions
Why is NAD+ slower than standard drips?
Because infusion rate affects tolerability. A slower pace is part of the protocol, not a drawback.
Should the page show exact session duration?
It should show realistic ranges because the session can vary by dose and patient tolerance.
Why require screening first?
Because not every patient who wants more energy automatically needs NAD+, and longer premium sessions should be matched to the right use case.
Can this page use request-first rather than instant booking?
Yes. That is often the better workflow for premium services that require review before confirmation.
Does doctor approval have to be visible on the page?
Yes. If approval is required, the patient should know that before they enter the booking flow.
Can NAD+ be offered as part of a series?
Yes. The page model should support structured programs as well as one-time interest requests.